Difference between revisions of "COVID-19 Protein"
| Line 2: | Line 2: | ||
==Protein Data Bank== | ==Protein Data Bank== | ||
https://www.rcsb.org/ | https://www.rcsb.org/ | ||
| + | |||
[https://www.rcsb.org/news?year=2020&article=5e74d55d2d410731e9944f52&feature=true PDB: COVID-19/SARS-CoV-2 Resources] | [https://www.rcsb.org/news?year=2020&article=5e74d55d2d410731e9944f52&feature=true PDB: COVID-19/SARS-CoV-2 Resources] | ||
Revision as of 12:53, 20 April 2021
Protein Data Bank
PDB: COVID-19/SARS-CoV-2 Resources
Videos
Animation of SARS-CoV-2 entry into human host-cell.
C&EN Articles
Structural biologists clean up SARS-CoV-2 protein structures
Protein mapping finds 69 potential treatments for COVID-19 Many are FDA-approved drugs that could be repurposed by Leigh Krietsch Boerner MARCH 26, 2020 | APPEARED IN VOLUME 98, ISSUE 12
UT Austin and Mount Sinai partner to create low-cost COVID-19 vaccine Clinical trials begin with the second generation of the SARS-CoV-2 spike protein, called HexaPro by Ryan Cross APRIL 8, 2021 | APPEARED IN VOLUME 99, ISSUE 13
8 tools that helped us tackle the coronavirus In the past year, researchers worked at a breakneck pace to understand, diagnose, treat, and prevent COVID-19. These technologies were critical to their success by Ryan Cross , Laura Howes , Megha Satyanarayana JANUARY 25, 2021 | APPEARED IN VOLUME 99, ISSUE 3
The tiny tweak behind COVID-19 vaccines Prepandemic coronavirus research by Jason McLellan and Barney Graham led to a trick for stabilizing the prefusion form of spike proteins by Ryan Cross SEPTEMBER 29, 2020 | APPEARED IN VOLUME 98, ISSUE 38